Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
27th April 2012 - Recipharm Ltd in Ashton under Lyne, UK is pleased to launch a dedicated recovery service for reworking pharmaceutical products under cGMP conditions at its UK site.
read more
Recipharm has announced the launch of its standalone serialization service ahead of the introduction of the EU Falsified Medicines Directive.
read more
Wednesday, October 12, 2016
Recipharm, the contract development and manufacturing organization (CDMO), has launched a showcase line for serialization, offering pharmaceutical companies the chance to view and trial its solution to the new European and US regulations.
read more
Recipharm has launched its end-to-end inhalation offering to provide customers with a fully integrated service from early stage development through to commercial manufacturing.
read more
Global contract development and manufacturing organisation (CDMO), Recipharm, has announced the completion of a new analytical laboratory at its facility in Bengaluru, India. The new lab has been in operation since August 1 2021.
read more
Thursday, November 14, 2019
Recipharm has announced it is joining the AMR Industry Alliance to contribute to exploring solutions to tackle growing concerns around antimicrobial resistance.
read more
Recipharm Venture Fund AB has together with Östersjöstiftelsen and Praktikerinvest made a joint investment of SEK 28 million in Pharmanest AB
read more
Wednesday, February 23, 2022
Recipharm is investing to expand its sterile fill and finish production capabilities at its site in Monts, France. The manufacturing facility which specializes in the aseptic filling of pharmaceutical products, including biologics into vials and ...
read more
Wednesday, November 02, 2016
Recipharm has announced an investment of over €1.2 million to enhance its small scale GMP active pharmaceutical ingredient (API) development and manufacturing capabilities in Paderno Dugnano, Italy.
read more
Recipharm has established a dedicated taskforce to manage the potential impact of Brexit on its organization.
read more
Thursday, December 10, 2020
Recipharm has announced an investment and capacity expansion at its facility in Israel.
read more
Recipharm has announced a €3.7 million investment to expand its lyophilization capacity in Masate, Italy, in response to growing customer demand.
read more
Recipharm has announced an €18 million investment to expand its blow fill seal (BFS) capacity at its site in Kaysersberg, France
read more
Wednesday, February 17, 2021
Recipharm, has extended its manufacturing license to include immunology products.
read more
Wednesday, August 31, 2016
Recipharm, the contract development and manufacturing organization (CDMO), has entered into a long term supply agreement with Tillotts Pharma AG.
read more